Lee Su Nam, Moon Donggyu, Jo Min Seop, Yoo Ki-Dong
Department of Internal Medicine.
Department of Thoracic and Cardiovascular Surgery, St. Vincent's Hospital, The Catholic University of Korea, Seoul, South Korea.
Acta Cardiol Sin. 2020 Sep;36(5):448-455. doi: 10.6515/ACS.202009_36(5).20200519B.
Previous studies have reported a "body mass index (BMI) paradox" with acute myocardial infarction (AMI), whereby overweight patients are associated with lower mortality. The aim of this study was to evaluate the impact of BMI on survival of patients with AMI supported with extracorporeal membrane oxygenation (ECMO).
Between May 2009 and July 2018, 60 patients with AMI who underwent ECMO were enrolled from a single center. Receiver operating characteristic curve analysis was used to determine a cutoff for BMI. Patients were divided into two groups: normal weight (18.5 ≤ BMI < 23 kg/m, n = 27) and overweight (BMI ≥ 23 kg/m, n = 33). The composite outcome was all-cause mortality at 30 days.
The overweight group was significantly younger than the normal weight group, and there was a statistically significant difference between the two groups in electrocardiography before ECMO. Ventricular tachycardia or fibrillation occurred in 11 (33.3%) overweight patients, and asystole or pulseless electrical activity occurred in 10 (37%) normal weight patients. More of the normal weight group had successful percutaneous coronary interventions than the overweight group. The overweight group was significantly associated with lower mortality [hazard ratio (HR): 0.491; 95% confidence interval (CI) = 0.267-0.903] at 30 days, which persisted after multivariate adjustments (HR: 0.442; 95% CI = 0.210-0.928). To determine predictive factors for mortality, multivariate logistic analysis revealed that overweight [odds ratio (OR) 0.102; 95% CI (0.018-0.564); p = 0.009] and ECMO under cardiopulmonary resuscitation [OR 19.009; 95% CI (2.139-168.956); p = 0.008] were significantly associated with all-cause mortality at 30 days.
Overweight was associated with lower mortality in AMI patients supported with ECMO.
既往研究报道急性心肌梗死(AMI)存在“体重指数(BMI)悖论”,即超重患者的死亡率较低。本研究旨在评估BMI对接受体外膜肺氧合(ECMO)支持的AMI患者生存的影响。
2009年5月至2018年7月,从单一中心纳入60例接受ECMO治疗的AMI患者。采用受试者工作特征曲线分析确定BMI的临界值。患者分为两组:正常体重组(18.5≤BMI<23kg/m,n=27)和超重组(BMI≥23kg/m,n=33)。复合结局为30天全因死亡率。
超重组患者明显比正常体重组患者年轻,两组在接受ECMO治疗前的心电图表现存在统计学显著差异。11例(33.3%)超重患者发生室性心动过速或颤动,10例(37%)正常体重患者发生心搏停止或无脉电活动。正常体重组成功进行经皮冠状动脉介入治疗的患者比超重组更多。超重组在30天时的死亡率显著较低[风险比(HR):0.491;95%置信区间(CI)=0.267-0.903],多变量调整后该结果仍然存在(HR:0.442;95%CI=0.210-0.928)。为确定死亡率的预测因素,多变量逻辑分析显示超重[比值比(OR)0.102;95%CI(0.018-0.564);p=0.009]和心肺复苏下的ECMO[OR 19.009;95%CI(2.139-168.956);p=0.008]与30天全因死亡率显著相关。
在接受ECMO支持的AMI患者中,超重与较低的死亡率相关。